Last Posted: Nov 29, 2018
- Newborn Screening for Severe Combined Immunodeficiency in the United States: Lessons Learned.
Dorsey Morna J et al. Immunology and allergy clinics of North America 2019 Feb 39(1) 1-11 - Transplantation of Hematopoietic Stem Cells for Primary Immunodeficiencies in Brazil: Challenges in Treating Rare Diseases in Developing Countries.
Fernandes Juliana Folloni et al. Journal of clinical immunology 2018 Nov - Detecting 22q11.2 Deletion Syndrome in Newborns with Low T Cell Receptor Excision Circles from Severe Combined Immunodeficiency Screening.
Liao Hsuan-Chieh et al. The Journal of pediatrics 2018 Sep - Newborn Screening for Severe Combined Immunodeficiency: Analytic and Clinical Performance of the T Cell Receptor Excision Circle Assay in France (DEPISTREC Study).
Audrain Marie A P et al. Journal of clinical immunology 2018 Sep - T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency.
Clarke Erik L et al. Genome medicine 2018 Sep (1) 70 - Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.
Kohn Donald B et al. The Journal of allergy and clinical immunology 2018 Sep - Lessons for Sequencing from the Addition of Severe Combined Immunodeficiency to Newborn Screening Panels.
Puck Jennifer M et al. The Hastings Center report 2018 Jul 48 Suppl 2S7-S9 - Newborn screening using TREC/KREC assay for severe T and B cell lymphopenia in Iran.
Nourizadeh Maryam et al. Scandinavian journal of immunology 2018 Jun e12699 - Twenty-Five Years of Gene Therapy for ADA-SCID: From Bubble Babies to an Approved Drug.
Ferrua Francesca et al. Human gene therapy 2017 Nov 28(11) 972-981 - SCID Newborn Screening Campaign
IDF, 2018
.png)
No hay comentarios:
Publicar un comentario